Infective pulmonary exacerbation of cystic fibrosis
(UMLS:C2938941)
- UMLS ID:
- C2938941
- MeSH ID:
- N/A
Synonym(s)
1.
Infective pulmonary exacerbation of cystic fibrosis
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | lumacaftor, ivacaftor drug combination | FAERS: 364 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 2 | 2-[(E)-[1-(2-Amino-1,3-thiazol-4-yl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-2-methylpropanoic acid;(2S)-2,6-diaminohexanoic acid | FAERS: 171 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 3 | ivacaftor | FAERS: 151 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 4 | Tobramycin | FAERS: 50 | US FAERS | |
| 5 | Aztreonam | FAERS: 17 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 6 | ambrisentan | FAERS: 4 | US FAERS | |
| 7 | colistinmethanesulfonic acid | FAERS: 2 | US FAERS | |
| 8 | Budesonide | FAERS: 1 | US FAERS | |
| 9 | Gentamicins | FAERS: 1 | US FAERS | |
| 10 | Ibuprofen | FAERS: 1 | US FAERS | |
| 11 | Lubiprostone | FAERS: 1 | US FAERS | |
| 12 | Tacrolimus | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.